-
Mashup Score: 8Flow diverters “particularly effective” but also associated with “non-negligible” complication rate in distal ACA aneurysms - 2 month(s) ago
An analysis presented at this year’s European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (4–6 September, Marseille, France) has indicated that flow diverters are “particularly effective” in the treatment of unruptured, distal anterior cerebral artery (ACA) aneurysms, while also highlighting the potential risk of ischaemic complications associated with this approach. The analysis in question […]
Source: neuronewsinternational.comCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 15
Royal Philips and the World Stroke Organization (WSO) have published a joint policy paper calling for a “revolution in stroke care” to make a real difference to the lives of millions and bring significant economic benefits worldwide. A Philips press release notes that, thanks to new technologies, procedures and clinical insights, stroke may be prevented, treated and even reversed if […]
Source: neuronewsinternational.comCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 14Remedy announces Phase 3 CHARM trial data indicating Cirara’s potential in large hemispheric infarction - 2 month(s) ago
Remedy Pharmaceuticals recently announced promising new data from the Phase 3 CHARM clinical trial of Cirara (intravenous glyburide) in patients with large hemispheric infarction (LHI)—a serious form of ischaemic stroke characterised by large volume lesions that can lead to malignant brain swelling, severe disability, and death. The analysis revealed significant and clinically meaningful improvements in patients’ […]
Source: neuronewsinternational.comCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 0HBA Support announces new patient-centred projects ahead of transition to registered charity status - 2 month(s) ago
Hereditary Brain Aneurysm (HBA) Support—a not-for-profit organisation providing information and support for individuals and families affected by hereditary brain aneurysms—has announced the upcoming launch of multiple projects intended to improve care and support for patients with familial brain aneurysms. In addition, the organisation is currently building up a campaign referred to as ‘Hope on the […]
Source: neuronewsinternational.comCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 3Arissa Medical enrols third cohort of patients in first-in-human Syntra pilot study - 3 month(s) ago
Arissa Medical has announced the third enrolment of patients into its Syntra study—an early feasibility pilot study evaluating the safety and efficacy of the company’s Syntra device for the treatment of irregular, wide-necked sidewall and wide-necked bifurcation cerebral aneurysms. Third-cohort cases in the study were successfully performed at Instituto de Neurocirugía Dr Alfonso Asenjo in […]
Source: neuronewsinternational.comCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 1Synchron announces first use of Apple Vision Pro with brain-computer interface device - 3 month(s) ago
Synchron has announced the world’s first-ever use of Apple Vision Pro by one of the patients implanted with the Synchron brain-computer interface (BCI). Mark, a 64-year-old man with amyotrophic lateral sclerosis (ALS), successfully used his direct thoughts to control the cursor on the Apple Vision Pro as he played Solitaire, watched Apple TV and sent […]
Source: neuronewsinternational.comCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 6
Despite mechanical thrombectomy’s high success rate in saving the lives of stroke patients, Medicare is paying lower rates over time for the procedure in the USA. That is according to three separate studies presented earlier this week at the Society of NeuroInterventional Surgery (SNIS) annual meeting (22–26 July, Colorado Springs, USA). These studies highlight worsening […]
Source: neuronewsinternational.comCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 70The modified Rankin scale as a stroke trial endpoint: important, but not all-encompassing - 4 month(s) ago
The modified Rankin scale (mRS) is something of a default clinical outcome metric in many contemporary stroke studies, but—as Eva Mistry and Paul Wechsler (both Cincinnati, USA) write in this NeuroNews guest article—represents an imperfect method for measuring success, and the time may therefore be right to re-evaluate its usage in stroke research. John Rankin […]
Source: neuronewsinternational.comCategories: General Medicine News, NephrologyTweet
-
Mashup Score: 3
The European Stroke Organisation (ESO) Executive Committee’s Thrombolysis Taskforce has provided “important updates” regarding the security of supply for Metalyse (tenecteplase) and Actilyse (alteplase) in the context of the European launch of Metalyse 25mg for acute ischaemic stroke treatment. The European Medicines Agency (EMA) approved the use of Metalyse 25mg earlier this year, on 12 […]
Source: neuronewsinternational.comCategories: General Medicine News, NeurologyTweet
-
Mashup Score: 7
Siemens Healthineers and the World Stroke Organization (WSO) have announced a two-year partnership to develop the acute stroke workforce, and improve treatment and care for stroke. Stroke is the second-leading cause of death and the third-leading cause of disability in adults—and, as stated in a joint press release from Siemens and the WSO, its incidence […]
Source: neuronewsinternational.comCategories: General Medicine News, NeurologyTweet
Flow diverters “particularly effective” but also associated with “non-negligible” complication rate in distal ACA aneurysms https://t.co/iEve6HwKgF